Jasmiel 28 Day Pack

RxCUI
2106997
RxNorm name
Jasmiel 28 Day Pack
Display name
Jasmiel 28 Day Pack
Full name
Jasmiel 28 Day Pack
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:49

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
JasmielDROSPIRENONE AND ETHINYL ESTRADIOLAfaxys Pharma, LLC1a3211f8-41f5-4905-a466-0d79add5fdad2024-05-14Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2106997

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
1a3211f8-41f5-4905-a466-0d79add5fdad{24 (drospirenone 3 MG / ethinyl estradiol 0.02 MG Oral Tablet) / 4 (inert ingredients 1 MG Oral Tablet) } Pack [Jasmiel 28 Day] [BPCK] · Jasmiel 28 Day Pack [PSN] · Jasmiel 28 Day Pack [SY]311These highlights do not include all the information needed to use JASMIEL safely and effectively. See full prescribing information for JASMIEL. JASMIEL ® (drospirenone and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 200120240514
653e7f67-67b7-478e-b36b-5e3189d4fe3e{24 (drospirenone 3 MG / ethinyl estradiol 0.02 MG Oral Tablet) / 4 (inert ingredients 1 MG Oral Tablet) } Pack [Jasmiel 28 Day] [BPCK] · Jasmiel 28 Day Pack [PSN] · Jasmiel 28 Day Pack [SY]33These highlights do not include all the information needed to use JASMIEL safely and effectively. See full prescribing information for JASMIEL. JASMIEL ® (drospirenone and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 200120230607